Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-015453

Cytosorbents Corp · CTSO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kathleen P. Bloch
Officer — Chief Financial Officer
Period of report
Mar 15, 2018
Accepted (ET)
Mar 19, 2018 · 10:18 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 15, 2018M11,176$4.69A261,246D
Common StockF2Mar 15, 2018S11,176$8.25D250,070D
Common StockF3holding———9,000ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)$4.69Mar 15, 2018M11,176DJan 30, 2017Jun 7, 2026Common Stock11,17624,920D

Explanation of responses